Bibliographic Details
Title: |
Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial |
Authors: |
Bear, Harry D, Tang, Gong, Rastogi, Priya, Geyer, Charles E, Jr, Liu, Qing, Robidoux, André, Baez-Diaz, Luis, Brufsky, Adam M, Mehta, Rita S, Fehrenbacher, Louis, Young, James A, Senecal, Francis M, Gaur, Rakesh, Margolese, Richard G, Adams, Paul T, Gross, Howard M, Costantino, Joseph P, Paik, Soonmyung, Swain, Sandra M, Mamounas, Eleftherios P, Wolmark, Norman |
Source: |
In The Lancet Oncology September 2015 16(9):1037-1048 |
Database: |
ScienceDirect |